BioCryst Pharmaceuticals
BCRX
#4657
Rank
HK$17.82 B
Marketcap
HK$70.14
Share price
0.34%
Change (1 day)
-10.38%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of March 2026 : HK$3.64 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are HK$3.64 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31HK$4.00 B5.07%
2024-12-31HK$3.80 B-5.7%
2023-12-31HK$4.03 B-6.05%
2022-12-31HK$4.29 B-6.3%
2021-12-31HK$4.58 B76.75%
2020-12-31HK$2.59 B90.08%
2019-12-31HK$1.36 B18.72%
2018-12-31HK$1.14 B-17.44%
2017-12-31HK$1.39 B99.9%
2016-12-31HK$0.69 B-26.53%
2015-12-31HK$0.94 B-10.67%
2014-12-31HK$1.06 B180.18%
2013-12-31HK$0.37 B-14.89%
2012-12-31HK$0.44 B-30.27%
2011-12-31HK$0.63 B-25.04%
2010-12-31HK$0.85 B-22.74%
2009-12-31HK$1.10 B68.46%
2008-12-31HK$0.65 B-41.19%
2007-12-31HK$1.11 B108.91%
2006-12-31HK$0.53 B-30.78%
2005-12-31HK$0.76 B204.97%
2004-12-31HK$0.25 B8.16%
2003-12-31HK$0.23 B-27.57%
2002-12-31HK$0.32 B-30.11%
2001-12-31HK$0.46 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
HK$441.01 B 12,001.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$652.45 B 17,803.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$24.91 B 583.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$22.96 B 530.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$8.17 B 124.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$4.00 B 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$65.48 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$0.22 B-93.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.44 B 214.16%๐Ÿ‡บ๐Ÿ‡ธ USA